Market revenue in 2023 | USD 1,221.9 million |
Market revenue in 2030 | USD 1,802.8 million |
Growth rate | 5.7% (CAGR from 2023 to 2030) |
Largest segment | Consulting |
Fastest growing segment | Regulatory Affairs |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Consulting, Regulatory Affairs, Product Design & Development, Auditing and Assessment, Product Maintenance, Training & Education |
Key market players worldwide | PAREXEL, IQVIA Holdings Inc, Heidelberg Materials AG, Labcorp Holdings Inc, Charles River Laboratories International Inc, Icon PLC, Syneos Health, Lonza Group Ltd, Catalent Inc, Samsung BioLogics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biotechnology and pharmaceutical services outsourcing market will help companies and investors design strategic landscapes.
Consulting was the largest segment with a revenue share of 43.82% in 2023. Horizon Databook has segmented the Canada biotechnology and pharmaceutical services outsourcing market based on consulting, regulatory affairs, product design & development, auditing and assessment, product maintenance, training & education covering the revenue growth of each sub-segment from 2018 to 2030.
According to the Government of Canada, Canada has one of the highest numbers of biotechnology companies across the globe focused on human health, giving the country a strong record of achievement in biopharmaceuticals.
In addition, the notable trend toward outsourcing drug development & production to CROs, CMOs, and CDMOs and leveraging their expertise & specialized services is fueling market growth in Canada.
Moreover, the rising technological innovations, growing demand for personalized medicine, and increasing number of clinical trials in Canada are some of the major factors expected to improve the demand for biotechnology & pharmaceutical services outsourcing.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada biotechnology and pharmaceutical services outsourcing market , including forecasts for subscribers. This country databook contains high-level insights into Canada biotechnology and pharmaceutical services outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account